ADVERTISEMENT
Analysts Say These Three Factors May Cap Torrent Pharma’s Growth
Shares of Torrent Pharma jumped 51% in the last 12 months.
02 Jun 2020, 03:19 PM IST
Torrent Pharmaceuticals Ltd. beat most of its larger peers in the last one year, aided by domestic business when Indian drugmakers faced pricing pressure in the U.S., and benefits of its Unichem Laboratories Ltd. deal.Analysts now see a limited upside citing lack of product pipeline and high valuations.Shares of the Ahmedabad-based drugmaker jumped 49% in the twelve-month period compared with a 14-48% gain in domestic peers and a 17%...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT